IQVIA Holdings Inc.

IQVNYSEUSD
184.39 USD
13.11 (7.66%)🟢LIVE (AS OF 01:51 PM EDT)
🟢Market: OPEN

IQVIA Holdings Inc. (IQV) trades at $184.39 per share. IQV shows a split signal: underlying fundamentals suggest "Buy" while technical indicators indicate "Sell". Notable factors include exceptional Return on Equity (22.3%) and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 23, 2026.

Open?$174.69
High?$184.52
Low?$168.87
Prev. Close?$171.28
Volume?782.4K
Avg. Volume?1.7M
VWAP?$182.85
Rel. Volume?0.46x
Bid / Ask
Bid?$184.04 × 100
Ask?$184.30 × 100
Spread?$0.26
Midpoint?$184.17
Valuation & Ratios
Market Cap?28.6B
Shares Out?166.9M
Float?160.5M
Float %?94.6%
P/E Ratio?20.64
P/B Ratio?4.60
EPS?$8.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Employees
93.0K
Market Cap
28.6B
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed
2013-05-09
Address
2400 ELLIS ROAD
DURHAM, NC 27703
Phone: 919-998-2000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
41
Momentum?
90
Short Sent.?
75
Piotroski F-Score?5/9Mixed
Altman Z-Score?2.16Grey
Confidence?70%Moderate
Full Fundamental Analysis →
Short InterestLow
Short % of Float?3.05%Low
Short Interest?4.9M
Days to Cover?2.6
Free Float160.5M
Avg Daily Volume1.9M
Settlement Date2026-05-29
Financial Health
Current Ratio?0.75Weak
Quick Ratio?0.75Weak
Cash Ratio?0.23Low
Debt/Equity?2.55High
ValuationATTRACTIVELY VALUEDvs 10 peers + S&P 500
Score
83/100
P/E?
Peers
100
S&P
63
20.6FAIR
P/B?
Peers
40
S&P
39
4.60FAIR
P/S?
Peers
100
S&P
74
1.72CHEAP
P/FCF?
Peers
100
S&P
79
13.5CHEAP
EV/EBITDA?
Peers
100
S&P
67
12.2FAIR
EV/Sales?
Peers
100
S&P
67
2.55CHEAP
Returns & Efficiency
ROE?
Peers
89
S&P
70
22.3%STRONG
ROA?
Peers
50
S&P
42
4.7%FAIR
Cash Flow & Enterprise
FCF?$2.1B
Enterprise Value?$42.5B
Fundamentals ratios updated end of day